Technical and economic bases of plant raw materials medicines introduction

Authors

DOI:

https://doi.org/10.24959/uekj.17.21

Keywords:

phytopreparations, implantation, Valerian Turkestan, Turkestan motherwort, Republic of Kazakhstan

Abstract

The article is devoted to promising areas for innovation inKazakhstan’s Pharmacy – create medicines using medicinal plants.

Aim. Is to carry out a feasibility study for implementation in production of new herbal medicines with sedative effect.

Materials and methods. We used methods of marketing research, as well as economic and statistical analysis methods. The information base for the study were the data of the Kazakh state register of medicines, market research companies, the legal framework for the development and registration of drugs.

Results. The structural analysis of the pharmaceutical market inKazakhstan, analysis of consumer preferences in the sedative group medicines showed that the drugs are in strong demand, however, the desired sales volumes and the assortment width for the domestic producer have not yet been achieved. The next stage was the technical and economic reasoning of introduction a new herbal medicines on the basis of Valerian Turkestan and Turkestan motherwort, growing inKazakhstan.

Conclusions. The analysis shows that there are no domestic phytodrugs created according to GMP standards and GACP principles in theKazakhstan pharmaceutical market. The technical and economic bases for the production of herbal medicine “Sedocaps” (capsules) showed the economic feasibility of the project and return on investment for three years with minimal investment, within six years – at the maximum.

References

Zhaparkulova, K. A., Moldakarimova, M. D., Sakipova, Z. B. (2013). Vesnik KazNMU, 5 (3), 104−105.

Kazbekov, B. K., Kazbekova, Zh. B. (2013). GISAP (Medical Science. Pharmacology), 1, 74–78.

Litvinenko, V. I., Popova, T. P., Dihtiarev, S. I., Popova, N. V., Maslova, N. F. (2012). Fitoterapiia, 2, 59–62.

Dobrovolnyi, O. O., Shalamai, A. S., Slobodianiuk, Yu. O. (2013). Farmatsevtychnyi chasopys – Pharmaceutical rewiew, 1, 113–118.

Botanical Drug Development. Guidance for Industry. Pharmaceutical Quality/CMC. (2016). Available at: https:// www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM458484.pdf

Turyshev, A. Yu., Sogrina, A. N., Yakovlev, A. B., Oleshko, G. I. (2010). Vestnik RUDN, 4, 475–477.

Zhadko, S. V. (2013). Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, 1, 46–50.

Litvinova, O. V., Posylkina, O. V. (2015). Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, 2, 69–75.

Slobodianiuk, M. M., Zhadko, S. V., Samborskyi, O. S. (2010). Ukrainskyi zhurnal klinichnoi ta laboratornoi meditsyny, 2, 58–62.

Posylkina, O. V., Bratishko, Yu. S., Svitlychna, K. S. (2015). Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, 3, 44–50.

Blair, J. (2010). Strategy of substituting for an import and its consequence for a national economy. Economic magazine, 11, 37.

Published

2017-06-15

Issue

Section

Management, economics in pharmacy